This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of new approaches to create devices/components with enhanced accuracy and less patient burden that will represent real advancements
regarding safety and effectiveness of glucose control technologies and their integration into open and closed loop hormone replacement systems.
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-21-011.html
Additional Information of Eligibility:Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Full Opportunity Web Address:http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-21-011.htmlContact: Agency Email Description: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email: Date Posted: 2021-05-06
Application Due Date: Archive Date: 2022-11-12